2022
DOI: 10.3390/s22072721
|View full text |Cite
|
Sign up to set email alerts
|

Comparative Analysis of Supervised Classifiers for the Evaluation of Sarcopenia Using a sEMG-Based Platform

Abstract: Sarcopenia is a geriatric condition characterized by a loss of strength and muscle mass, with a high impact on health status, functional independence and quality of life in older adults. [d=TT, ]To reduce the effects of the disease, just the diagnostic is not enough, it is necessary more than recognition.To reduce the effects of the disease, it is important to recognize the level and progression of sarcopenia early. Surface electromyography is becoming increasingly relevant for the prevention and diagnosis of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(12 citation statements)
references
References 49 publications
(48 reference statements)
0
11
0
Order By: Relevance
“…Since the primary goal is to develop an early screening tool, high sensitivity should be prioritized when considering the balance between sensitivity and specificity. As such, the optimal operating point (OOP) of ROC was chosen by the rule that it has the highest sensitivity while specificity is above the 0.65 threshold [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…Since the primary goal is to develop an early screening tool, high sensitivity should be prioritized when considering the balance between sensitivity and specificity. As such, the optimal operating point (OOP) of ROC was chosen by the rule that it has the highest sensitivity while specificity is above the 0.65 threshold [ 39 ].…”
Section: Resultsmentioning
confidence: 99%
“…SARC-F is the loss of muscle mass, being classified through scoring through a questionnaire answered by the volunteers. A score greater than four shows the probability of sarcopenia [ 34 ].…”
Section: Methodsmentioning
confidence: 99%
“…Gait Phase Detection [ 116 ]. Evaluation of sarcopenia based on sEMG platform [ 117 ]. Time-frequency muscle synergy estimation based on sEMG [ 118 ].…”
Section: Figurementioning
confidence: 99%